Back to screener
AstraZeneca Pharma India Limited
₹6,751.50
▲ 82.50 (+1.24%) today
Latest quote · Yahoo Finance
Market Cap
₹16.88K Cr
P/E (TTM)
99.3
P/B
19.3
Book Value
₹349.12
ROE
19.4%
Div Yield
0.54%
D/E
0.13
EPS (TTM)
₹68.02
52W High
₹9,849.50
52W Low
₹6,600.00
Sales Growth
+29.70%
Profit Growth
-32.10%
Day High
₹6,769.00
Day Low
₹6,678.00
Volume
4,635
Fundamentals refreshed 4 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at 99.3× trailing earnings
- • Strong ROE at 19.4%
- • Low leverage (D/E 0.13)
- • Modest dividend yield of 0.54%
- • Operating margin 6.4% · Net margin 7.0%
- • Profit growth -32.10% YoY · Beta 0.22
Employees: 600
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 683 | +17.96% | +29.85% |
| Operating Profit | 58 | -12.12% | -36.96% |
| Net Profit | 38 | -15.56% | -32.14% |
| EPS (₹) | 15.17 | -15.49% | -32.06% |
OPM 8.5% · Net margin 5.6% · prev quarter OPM 11.4%
Loading shareholding pattern…
Loading block / bulk / insider deals…
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
